Chemistry analyzer reagent for D-Dimer quantification. Applicable to thrombotic and cardiovascular assessments, compatible with standard automated analyzer platforms.
Manufactured by
Tukwila, WA, United States
KAMIYA BIOMEDICAL COMPANY was founded by Kohji Kamiya in March of 1983 in Thousand Oaks, California and relocated to Seattle, Washington in 1996. Our company's purpose is supplying the life science and medical communities with innovative laboratory research and diagnostic tools of the highest quality. KAMIYA is an independent American company that serves worldwide markets. Since 1983 The company's first products were protein kinase inhibitors, staurosporine and its analog, K252a. Staurosporine was discovered in 1977 by Dr. Satoshi Ohmura who is a 2015 Nobel Prize winner. This was the first commercially available staurosporine. Today, staurosporine is one of the most popular research tools in life science research fields. Today, KAMIYA's life science product lines include thousands of human and animal biomarker assays for preclinical testing with one of the largest selections of ELISA kits in the world. KAMIYA continues to offer a variety of other life science research products including enzyme inhibitors and monoclonal / polyclonal antibodies for use in a variety of fields including apoptosis, multidrug resistance, oxidative / DNA damage and repair, bone biology, cancer, cardiac health, inflammation, stress, obesity, and diabetes. In 1997, KAMIYA introduced a full line of clinical diagnostic and research immunoassay products for lipid assessment, coagulation, inflammation, diabetes, nutritional assessment, and serum protein measurement based on immunoturbidimetric technology. The K-ASSAY reagents were developed for use on standard chemistry analyzers, requiring no mixing, dissolving, or dilution of reagent or sample, at an exceptional value. Recently, KAMIYA has introduced new innovative K-ASSAY chemistry analyzer reagents for Insulin, D-Dimer, Factor XIII, Plasma FDP, Serum/Urine FDP, and Total IgE testing. KAMIYA now has the broadest product line of liquid serum protein immunoassay reagents of any company in the U.S. We supply clinical diagnostic reagents to leading hospitals, medical centers, clinical laboratories, clinical reference labs, research facilities, distributors, and diagnostic instrument companies worldwide. Look for KAMIYA BIOMEDICAL COMPANY to continue to offer the life science and medical communities with innovative and cutting edge laboratory research and diagnostic tools!
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Nanjing Leading Medical Technology Co. Ltd.
China · 4 relevant products
Zhejiang Pushkang Biotechnology Co., Ltd.
China · 3 relevant products
Boditech Med Inc.
South Korea · 2 relevant products
Biogenix Inc Private Limited
India · 2 relevant products
Beijing CNB Biotech Co., Ltd.
China · 2 relevant products
Beijing Strong Biotechnologies, Inc.
China · 2 relevant products
Sekbio Co., Ltd
China · 1 relevant product
Shanghai Sun Biotech Co., Ltd
China · 4 relevant products
Nordic Biomarker AB
Sweden · 11 relevant products
Aniara Diagnostica
United States · 1 relevant product
51 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 95 closest product alternatives
Nanjing Leading Medical Technology Co. Ltd. · China
Biochemical reagent for detecting D-dimer levels to evaluate thrombotic disorders including deep vein thrombosis and pulmonary embolism. Essential for coagulation assessment in clinical laboratories.
Zhejiang Pushkang Biotechnology Co., Ltd. · China
Immunoassay reagent for D-dimer quantification using chemiluminescent or immunoturbidimetric detection. Supports thromboembolism risk assessment and fibrinolysis monitoring.
Boditech Med Inc. · South Korea
A diagnostic reagent for measuring D-dimer levels in blood with a testing time of approximately 12 minutes. It is used to assess thrombotic conditions and aid in clinical decision-making.
Biogenix Inc Private Limited · India
A turbidimetric reagent designed for D-dimer measurement in clinical laboratories. Supplied in 40ML pack size for use with laboratory analyzers. Used for thrombosis and coagulation disorder diagnostics.
Beijing CNB Biotech Co., Ltd. · China
A ready-to-use liquid reagent for D-dimer measurement, used for thrombosis and hemostasis screening and diagnosis to support disease state management in clinical laboratories.
Beijing Strong Biotechnologies, Inc. · China
A reagent kit for measuring D-dimer levels in blood. Serves as a specific indicator for exclusion of venous thromboembolism in clinical diagnostics.
Sekbio Co., Ltd · China
A bulk chemiluminescence immunoassay kit for quantitative measurement of D-Dimer, a fibrin degradation product used as a laboratory marker for thrombotic disorders including deep vein thrombosis (DVT) and pulmonary embolism (PE). The assay uses an acridinium ester (AE) chemiluminescent label with magnetic bead capture for high-sensitivity detection, completing the full assay cycle in 5 minutes. Formulated for integration with AE-platform chemiluminescence analyzers, it provides analytical performance with within-run CV ≤3.3% and signal-to-noise ratio exceeding 11,500 at the upper calibrator.
Shanghai Sun Biotech Co., Ltd · China
A diagnostic reagent for fibrinolysis system testing, measuring D-Dimer and fibrin degradation products (FDP). Used to assess fibrinolytic activity and diagnose thrombotic or fibrinolytic disorders in clinical laboratories.
Nordic Biomarker AB · Sweden
CE-marked under IVDR 2017/746 for D-dimer measurement in coagulation analysis. Used for assessment of fibrinolysis and thrombotic disorders.
Aniara Diagnostica · United States
Specific reagent for monitoring dabigatran concentration in anticoagulated patients. Enables accurate DOAC level assessment in coagulation laboratories.
Nordic Biomarker AB · Sweden
Specialty coagulation reagent for measurement of antithrombin levels in patient samples. CE-marked for diagnostic use on coagulation analyzers.
Zhejiang Pushkang Biotechnology Co., Ltd. · China
Quantitative assay reagent for fibrinogen measurement using optical detection methodology. Supports comprehensive hemostasis evaluation on automated coagulation platforms.
83 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products